Krishnakumar Chullipalliyalil

Dr. Krishnakumar Chullipalliyalil

CAPPA, Munster Technological University, Cork, Ireland
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2020 in Future Microbiology
Verified
Journal Article
Closed access
SDSteven Darby
Steven Darby
KCKrishnakumar Chullipalliyalil
Krishnakumar Chullipalliyalil
MPMilosz Przyjalgowski
Milosz Przyjalgowski
PMPaddy McGowan
Paddy McGowan
SJSimon Jeffers
Simon Jeffers
Roy SleatorRoy Sleator
Roy Sleator
Aim: Face masks are an important addition to our arsenal in the fight against COVID-19. The aim of this study is to present a novel method of measuring mask performance which can simultaneously ass... Graphical abstract Tweetable abstract Face masks are an effective means of stemming the spread of COVID-19. However, mask performance varies considerably depending on the fabric from which they are made, and how they...

25 January 2023 in Analytical Chemistry
Verified
Journal Article
Open access
KCKrishnakumar Chullipalliyalil
Krishnakumar Chullipalliyalil
KEKhaled Elkassas
Khaled Elkassas
MMMichael Anthony Patrick McAuliffe
Michael Anthony Patrick McAuliffe
SVSonja Vucen
Sonja Vucen
ACAbina Crean
Abina Crean
The conventional quality control techniques for identifying the denaturation of biopharmaceuticals includes sodium dodecyl sulfate-polyacrylamide gel electrophoresis for identifying fragmentation, ion exchange chromatography and isoelectric focusing for identifying deamidation, reverse-phase high-performance liquid chromatography (HPLC) for identifying oxidation, and size-exclusion HPLC for identifying aggregation. These stability assessments require essential processes that are destructive to the product tested. All these techniques are lab based and require sample removal from a sealed storage vial, which can breach the sterility. In this work, we investigate the heat- and surfactant-induced denaturation of an in-vial-stored model protein, bovine serum albumin (BSA), by analyzing its intrinsic fluorescence without removing the sample from the vial. A lab-based bespoke setup which can do the measurement in vial is used to demonstrate the change in fluorescence polarization of the protein to determine the denaturation level. The results obtained are compared to circular dichroism and size-exclusion HPLC measurements. The results prove that in-vial fluorescence measurements can be performed to monitor protein denaturation. A cost-effective portable solution to provide a top-level overview of biopharmaceutical product stability from manufacture to the point of patient administration can be further developed using the same technique.

11 December 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
KCKrishnakumar Chullipalliyalil
Krishnakumar Chullipalliyalil
LLLiam Lewis
Liam Lewis
MMMichael Anthony Patrick McAuliffe
Michael Anthony Patrick McAuliffe

11 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ADAnnachiara Dozzo
Annachiara Dozzo
KCKrishnakumar Chullipalliyalil
Krishnakumar Chullipalliyalil
MMMichael Anthony Patrick McAuliffe
Michael Anthony Patrick McAuliffe
COCaitriona M. O'Driscoll
Caitriona M. O'Driscoll
KRKatie B. Ryan
Katie B. Ryan
(1) Background: Three-dimensional (3D) in vitro, biorelevant culture models that recapitulate cancer progression can help elucidate physio-pathological disease cues and enhance the screening of more effective therapies. Insufficient research has been conducted to generate in vitro 3D models to replicate the spread of prostate cancer to the bone, a key metastatic site of the disease, and to understand the interplay between the key cell players. In this study, we aim to investigate PLGA and nano-hydroxyapatite (nHA)/PLGA mixed scaffolds as a predictive preclinical tool to study metastatic prostate cancer (mPC) in the bone and reduce the gap that exists with traditional 2D cultures. (2) Methods: nHA/PLGA mixed scaffolds were produced by electrospraying, compacting, and foaming PLGA polymer microparticles, +/− nano-hydroxyapatite (nHA), and a salt porogen to produce 3D, porous scaffolds. Physicochemical scaffold characterisation together with an evaluation of osteoblastic (hFOB 1.19) and mPC (PC-3) cell behaviour (RT-qPCR, viability, and differentiation) in mono- and co-culture, was undertaken. (3) Results: The results show that the addition of nHA, particularly at the higher-level impacted scaffolds in terms of mechanical and degradation behaviour. The nHA 4 mg resulted in weaker scaffolds, but cell viability increased. Qualitatively, fluorescent imaging of cultures showed an increase in PC-3 cells compared to osteoblasts despite lower initial PC-3 seeding densities. Osteoblast monocultures, in general, caused an upregulation (or at least equivalent to controls) in gene production, which was highest in plain scaffolds and decreased with increases in nHA. Additionally, the genes were downregulated in PC3 and co-cultures. Further, drug toxicity tests demonstrated a significant effect in 2D and 3D co-cultures. (4) Conclusions: The results demonstrate that culture conditions and environment (2D versus 3D, monoculture versus co-culture) and scaffold composition all impact cell behaviour and model development.

1 March 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
KEKhaled ElKassas
Khaled ElKassas
KCKrishnakumar Chullipalliyalil
Krishnakumar Chullipalliyalil
MMMichael McAuliffe
Michael McAuliffe
SVSonja Vucen
Sonja Vucen
ACAbina Crean
Abina Crean
Lyophilisation is a prominent technique used to create stabilised, dried forms of biopharmaceutical formulations. Reconstitution of lyophilised parenteral formulations is a key step prior to patient administration. The accurate determination of reconstitution time is a necessity to aid formulation development and support product quality control. Traditional methods for quantifying reconstitution time involve the visual identification of the endpoint, which has led to variable values reported across studies. In this work, the use of ultra-violet (UV) excited fluorescence spectroscopy as an alternative to the visual quantification of the reconstitution time was investigated. Spectrographic information was collected via a bespoke setup that allowed the measurement of the reconstitution time in a standard sealed lyophilisation vial. The spectra were analysed via principal component analysis (PCA) to obtain a time-based representation of the changes in a reconstituting formulation. The analysis was followed by the identification of an endpoint using three techniques ranging from fully automated to manual with regards to the required level of user input. At high protein concentration, the variability of the reconstitution time measurements was reduced from 80.4% relative standard deviation obtained via the traditional method to 8.2% for the instrumental method presented in.

6 October 2026 in Composites Part C: Open Access
Verified
Journal Article
Open access
FBFinbarr Buckley
Finbarr Buckley
MAMitra Abed
Mitra Abed
KRKieran Ruane
Kieran Ruane
PLPaul Leahy
Paul Leahy
KCKrishnakumar Chullipalliyalil
Krishnakumar Chullipalliyalil
VJVesna Jaksic
Vesna Jaksic